Emerging Company Profile
Umoja launches with $53M round to test cell therapy cocktails that expand CAR T cells within patients
Emerging Company Profile: Umoja to test in vivo approach with first-in-human trial next year
The company expects to test its in vivo approach with a first-in-human trial next year.
Nov 19, 2020 | 12:15 AM GMT